Sitaglu Met XR 100/1000mg Tablet – Extended-Release Dual Therapy
Sitaglu Met XR 100/1000mg Tablet – Extended-Release Dual Therapy
Description
Sitaglu Met XR 100/1000mg Tablet – Advanced Extended-Release Formula for All-Day Blood Sugar Control
Sitaglu Met XR 100/1000mg Tablet combines sitagliptin 100mg and extended-release metformin hydrochloride 1000mg to provide powerful, long-lasting management for adults with type 2 diabetes. Sitagliptin, a DPP-4 inhibitor, boosts incretin hormones to enhance glucose-dependent insulin release and lower glucagon levels, while the extended-release metformin gradually improves insulin sensitivity and reduces liver glucose production throughout the day. This dual-action approach delivers superior HbA1c reduction and stable control of fasting and post-meal blood sugar with the convenience of once-daily dosing.
Ideal for patients needing intensified therapy or better tolerability, this extended-release tablet minimizes gastrointestinal side effects common with immediate-release metformin, supporting consistent adherence and effective long-term glycemic management alongside diet and exercise under medical supervision.
